Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4921 Target Snapshot

Urotensin-2 receptor · SINGLE PROTEIN · Rattus norvegicus

255Compounds
105Assays
0Approved Drugs
346.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P49684. Use UniProt P49684 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P49684 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Urotensin-2 receptor as ChEMBL target CHEMBL4921, mapped to UniProt P49684. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Urotensin-2 receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL4921
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P49684
Urotensin-2 receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Urotensin-2 receptor is the right protein anchor across sources, using UniProt P49684 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelUrotensin-2 receptor
UniProt AccessionP49684
Component TypeProtein
Sequence Length386 aa

Urotensin-2 receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Urotensin-2 receptor, mapped to UniProt P49684. Sequence length is 386 aa.

Mapped IDP49684
Review nameUrotensin-2 receptor
OrganismRattus norvegicus
Assay Mix

Activity Type Distribution

IC5067.0
KI25.0
EC50249.0
KD5.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3315148 10.9 EC50 0.01259 Preclinical
CHEMBL3315144 10.71 EC50 0.0195 Preclinical
CHEMBL1165797 10.7 Ki 0.02 Preclinical
CHEMBL218994 10.0 EC50 0.1 Preclinical
CHEMBL1165734 9.96 EC50 0.11 Preclinical
CHEMBL577772 9.92 Ki 0.12 Preclinical
CHEMBL1163460 9.8 EC50 0.16 Preclinical
CHEMBL1163463 9.77 EC50 0.17 Preclinical
CHEMBL1163463 9.72 Ki 0.19 Preclinical
CHEMBL390094 9.6 EC50 0.2512 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
6
5.5
15
6.0
29
6.5
24
7.0
63
7.5
121
8.0
25
8.5
15
9.0
8
9.5
pChEMBL
Assay Landscape

Assay Landscape

105
Total Assays
111
Tested Compounds
2
Assay Types
Binding — 70 assays, 102 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 59 71 7.9
tissue-based format 8 21 8.6
cell-based format 2 10 8.3
assay format 1 0
Functional — 35 assays, 111 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 20 13 7.9
cell-based format 10 86 7.5
tissue-based format 5 12 8.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine